Literature DB >> 10957764

The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases.

A Pietinalho1, M Ohmichi, A B Löfroos, Y Hiraga, O Selroos.   

Abstract

BACKGROUND AND AIM OF THE STUDY: The frequency and clinical picture of sarcoidosis are different in Finland and Hokkaido, Japan. The aim of this study was to compare the normalisation rate of chest radiographic changes in patients with biopsy-proven sarcoidosis.
METHOD: The chest radiographs of 437 Finnish and 457 Japanese patients were used and, for the purpose of this study, double-checked in order to make sure that the interpretations were identical. On a yearly basis the radiographs were classified as normalised, improved, unchanged or deteriorated.
RESULTS: Normalisation of chest radiographs occurred in 73% of the Japanese and 40% of the Finnish patients. The difference between the two series was significant (p < 0.001). Gender, young age, presence or absence of symptoms or extrapulmonary lesions at diagnosis or treatment with corticosteroids did not influence the difference between the two series. Of the 191 Finnish and 309 Japanese patients with initial stage I disease a normal chest radiograph was obtained in 47% of the Finnish and 76% of the Japanese patients (p < 0.001), despite the fact that the Finnish series included patients with erythema nodosum, who had a 59% normalisation rate. Of the 186 Finnish and 125 Japanese patients with initial stage II disease, normalisation of the chest radiographs was seen in 36% of the Finnish and in 73% of the Japanese patients (p < 0.001). No difference in normalisation rate was seen between stage III patients.
CONCLUSION: The prognosis of pulmonary sarcoidosis in Japanese patients in Hokkaido is significantly better than that in Finland defined as normalisation rate of the chest radiographs.

Entities:  

Mesh:

Year:  2000        PMID: 10957764

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  12 in total

Review 1.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

2.  Outcome of pulmonary sarcoidosis: a population-based study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eva M Carmona; Eric L Matteson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Corticosteroid-Sparing Drugs in Sarcoidosis: How Should We Assess Them?

Authors:  Marc A Judson
Journal:  Lung       Date:  2021-04-07       Impact factor: 2.584

Review 4.  Neuro-ophthalmic sarcoidosis.

Authors:  Robert P Baughman; Kenneth L Weiss; Karl C Golnik
Journal:  Eye Brain       Date:  2012-03-13

5.  Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Douglas A Simonetto; Eric L Matteson
Journal:  Am J Gastroenterol       Date:  2017-09-05       Impact factor: 10.864

6.  Hospitalization Among Patients with Sarcoidosis: A Population-Based Cohort Study 1987-2015.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Sara J Achenbach; Eva M Carmona; Eric L Matteson
Journal:  Lung       Date:  2017-04-29       Impact factor: 2.584

Review 7.  Diagnosis of Sarcoidosis.

Authors:  Thomas E Wessendorf; Francesco Bonella; Ulrich Costabel
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

8.  Uveitis profile and treatment response in Iranian patients with sarcoidosis.

Authors:  Pouya Mahmoudzadeh; Adib Tousi; Alireza Ramezani; Roham Soheilian; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2014-06-12       Impact factor: 2.031

Review 9.  Pulmonary hypertension associated with sarcoidosis.

Authors:  Robert P Baughman
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  Positron emission tomography imaging in sarcoidosis.

Authors:  Beth Vettiyil; Nikitha Gupta; Rajesh Kumar
Journal:  World J Nucl Med       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.